Amgen (AMGN) director Michael V. Drake granted 63.8764 shares in equity award
Rhea-AI Filing Summary
Drake Michael V reported acquisition or exercise transactions in this Form 4 filing.
AMGEN INC director Michael V. Drake reported an automatic grant/award of 63.8764 shares of common stock on 2026-08-07, at a stated price of $0.0000 per share as compensation. Following this award, his directly held position is 5,876.1633 shares, including 377 Dividend Equivalents linked to unvested Restricted Stock Units that pay out in common stock on a one-to-one basis as they vest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 63.8764 shares
Net Buy
1 txn
Insider
Drake Michael V
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 63.8764 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 5,876.1633 shares (Direct)
Footnotes (1)
- F1. These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
Shares granted: 63.8764 shares
Post-transaction holdings: 5,876.1633 shares
Dividend Equivalents: 377
+1 more
4 metrics
Shares granted
63.8764 shares
Common Stock award on 2026-08-07, transaction code A
Post-transaction holdings
5,876.1633 shares
Directly held Amgen common stock after the award
Dividend Equivalents
377
DEs credited to unvested RSUs, paid out one-to-one in shares as they vest
Award price per share
$0.0000
Stated price for the granted Common Stock shares
Key Terms
Dividend Equivalents, Restricted Stock Units, equity incentive plan, qualifying dividend reinvestment plan
4 terms
Dividend Equivalents financial
"These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc."
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Restricted Stock Units financial
"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
equity incentive plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
qualifying dividend reinvestment plan financial
"and subject to a qualifying dividend reinvestment plan. DEs are credited"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Amgen (AMGN) director Michael V. Drake report in this Form 4?
Michael V. Drake reported an automatic grant of 63.8764 Amgen common shares as compensation on 2026-08-07. After this award, he directly holds 5,876.1633 shares of Amgen common stock, including Dividend Equivalents tied to unvested Restricted Stock Units.
What are the Dividend Equivalents mentioned in the Amgen (AMGN) Form 4?
The filing states that 377 Dividend Equivalents (DEs) were granted under Amgen’s equity incentive plan. These DEs are credited to unvested Restricted Stock Units and are paid out in common shares on a one-to-one basis according to the RSU vesting schedule.
Was the Amgen (AMGN) Form 4 transaction a market purchase or a compensation grant?
The transaction is reported with code A, described as a grant, award, or other acquisition of common stock. The shares were acquired at a stated price of $0.0000 per share, indicating a compensation-related equity award rather than an open-market purchase.
Which Amgen (AMGN) compensation plan governs the Dividend Equivalents in this Form 4?
The Dividend Equivalents were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. They are tied to the reporting person’s unvested Restricted Stock Units and follow the same vesting schedule as those RSUs.